PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsPlasmalyte
Plasmalyte
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
137 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Acute kidney injuryD058186—N172122814
Critical illnessD016638————1157
IschemiaD007511EFO_0000556—23—317
HypotensionD007022EFO_0005251I95——1236
ShockD012769—R57.1—11125
Heart diseasesD006331EFO_0003777I51.912—114
Acid-base imbalanceD000137——111114
Chronic limb-threatening ischemiaD000089802——11—214
Congenital heart defectsD006330—Q24.9——1113
HyponatremiaD007010—E87.1———112
Show 14 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Respiratory distress syndromeD012128EFO_1000637J80551——8
Acute lung injuryD055371EFO_0004610—442——8
Newborn respiratory distress syndromeD012127—P22441——7
SyndromeD013577——431——6
Covid-19D000086382—U07.1322——6
SepsisD018805EFO_0001420A41.9——2—35
OsteoarthritisD010003EFO_0002506M15-M19—31——4
Septic shockD012772—A48.3—11—24
Wounds and injuriesD014947—T14.8111—24
AcidosisD000138EFO_1000014E87.2——1—23
Show 25 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Knee osteoarthritisD020370EFO_0004616M17—3———3
Diabetes mellitusD003920EFO_0000400E08-E1322———3
Myocardial infarctionD009203EFO_0000612I2112——13
Coronary artery diseaseD003324—I25.112——13
CardiomyopathiesD009202EFO_0000318I42—3———3
SclerosisD012598——23———3
Depressive disorderD003866EFO_1002014F32.A22———3
Myocardial ischemiaD017202EFO_1001375I20-I2512———2
Coronavirus infectionsD018352EFO_0007224B34.221———2
PneumoniaD011014EFO_0003106J1821———2
Show 34 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
FibrosisD005355——2———13
Hiv infectionsD015658EFO_0000764B201———23
HemorrhageD006470MP_0001914R581———12
Zika virusD000071244——2————2
Type 1 diabetes mellitusD003922EFO_0001359E101————1
Autistic disorderD001321EFO_0003758F84.01————1
Autism spectrum disorderD000067877—F84.01————1
Pervasive child development disordersD002659EFO_0003756F841————1
Multiple myelomaD009101—C90.01————1
Plasma cell neoplasmsD054219——1————1
Show 15 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ToxemiaD014115——————33
Aortic valve diseaseD000082862——————22
Morbid obesityD009767EFO_0001074—————11
Reperfusion injuryD015427——————11
Brain edemaD001929EFO_1000845G93.6————11
Postpartum hemorrhageD006473—O72————11
Sudden infant deathD013398——————11
DeliriumD003693—R41.0————11
Emergence deliriumD000071257——————11
Central venous cathetersD062905——————11
Show 17 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
30 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use